secwatch.observer — SEC 8-K summary
======================================

Issuer:     PALVELLA THERAPEUTICS, INC. (PVLA)
CIK:        0001583648
Form:       8-K
Filed at:   2026-05-13T11:30:15+00:00
Accession:  0001193125-26-220607
Event type: other_material
Sentiment:  positive
Materiality: 0.45
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Palvella Therapeutics approved to uplist to Nasdaq Global Market on May 13
--------------------------------------------------------------------------

- Nasdaq approval for transfer from Capital Market to Global Market received May 11, 2026.
- Effective at open of business on May 13, 2026; ticker PVLA unchanged.
- Company will trade on the more prestigious Nasdaq Global tier.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1583648/000119312526220607/0001193125-26-220607-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1583648/000119312526220607/pvla-20260511.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-220607

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer